drugset / Trial / NCT03329560
Safety of FMT Using Oral Encapsulated PRIM-DJ2727 in HIV
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether oral fecal microbiota transplantation (FMT) is safe for people with human immunodeficiency virus (HIV) infection.
Timeline
- Start
- 2018-04-12
- Primary completion
- 2019-10-08
- Completion
- 2019-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PRIM-DJ2727 | Other / unclassified | — | Oral |